Transplant Surgery

The clinical course may be reconstructed from organ recovery and preservation records, ischemic time, implantation findings, reperfusion, operative complications, laboratory trends, imaging, pathology, and subsequent procedures. Depending on the organ and the expert’s qualifications, these records may help distinguish possible donor-related, preservation-related, technical, vascular, recipient-related, rejection, infectious, or other contributors to early graft dysfunction. Organ-specific medical or pathology expertise may also be appropriate when those issues are central to the case.

Living-donor transplantation involves evaluation and care of both the donor and recipient, along with planned organ recovery and implantation. Deceased-donor transplantation may place greater emphasis on donor information, organ allocation and acceptance, recovery, preservation, transportation, and the timing of transplantation. In either setting, the records can trace the organ from donor assessment and recovery through implantation and postoperative care.

Generally, no. A bone marrow transplant is a form of hematopoietic stem cell transplantation, in which blood-forming stem cells are given to restore or replace the patient’s hematopoietic system. Cases involving stem-cell collection, conditioning therapy, infusion, engraftment, rejection, graft-versus-host disease, or hematologic complications are generally more closely associated with hematology and hematopoietic stem cell transplantation than with solid-organ transplant surgery.